Randolph C Steer - Net Worth and Insider Trading

Randolph C Steer Net Worth

The estimated net worth of Randolph C Steer is at least $2 Million dollars as of 2024-11-13. Randolph C Steer is the Director of Bio-Techne Corp and owns about 20,448 shares of Bio-Techne Corp (TECH) stock worth over $2 Million. Details can be seen in Randolph C Steer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randolph C Steer has not made any transactions after 2021-09-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Randolph C Steer

Randolph C Steer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Randolph C Steer owns 4 companies in total, including Bio-Techne Corp (TECH) , Immunic Inc (IMUX) , and Capstone Holding Corp (CAPS) among others .

Click here to see the complete history of Randolph C Steer’s form 4 insider trades.

Insider Ownership Summary of Randolph C Steer

Ticker	Comapny	Transaction Date	Type of Owner
TECH	Bio-Techne Corp	2021-09-07	director
IMUX	Immunic Inc	2014-04-16	director
CAPS	Capstone Holding Corp	2007-05-21	President
		2005-05-11	director

Randolph C Steer Latest Holdings Summary

Randolph C Steer currently owns a total of 1 stock. Randolph C Steer owns 20,448 shares of Bio-Techne Corp (TECH) as of September 7, 2021, with a value of $2 Million.

Latest Holdings of Randolph C Steer

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TECH	Bio-Techne Corp	2021-09-07	20,448	74.40	1,521,331

Holding Weightings of Randolph C Steer

Randolph C Steer Form 4 Trading Tracker

According to the SEC Form 4 filings, Randolph C Steer has made a total of 2 transactions in Bio-Techne Corp (TECH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Bio-Techne Corp is the sale of 32,000 shares on September 7, 2021, which brought Randolph C Steer around $4 Million.

Insider Trading History of Randolph C Steer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Randolph C Steer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Randolph C Steer Ownership Network

Ownership Network List of Randolph C Steer

No Data

Ownership Network Relation of Randolph C Steer

Randolph C Steer Owned Company Details

What does Bio-Techne Corp do?

Who are the key executives at Bio-Techne Corp?

Randolph C Steer is the director of Bio-Techne Corp. Other key executives at Bio-Techne Corp include PRESIDENT & PROTEIN SCIENCES William Geist , director & Chief Executive Officer Charles R. Kummeth , and SVP - General Counsel Shane Bohnen .

Bio-Techne Corp (TECH) Insider Trades Summary

Over the past 18 months, Randolph C Steer made no insider transaction in Bio-Techne Corp (TECH). Other recent insider transactions involving Bio-Techne Corp (TECH) include a net sale of 80,322 shares made by Charles R. Kummeth , a net sale of 19,339 shares made by Roeland Nusse , and a net sale of 16,000 shares made by Robert V Baumgartner .

In summary, during the past 3 months, insiders sold 0 shares of Bio-Techne Corp (TECH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 119,661 shares of Bio-Techne Corp (TECH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 119,661 shares.

Bio-Techne Corp (TECH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bio-Techne Corp Insider Transactions

No Available Data

What does Immunic Inc do?

Who are the key executives at Immunic Inc?

Randolph C Steer is the director of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .

Immunic Inc (IMUX) Insider Trades Summary

Over the past 18 months, Randolph C Steer made no insider transaction in Immunic Inc (IMUX). Other recent insider transactions involving Immunic Inc (IMUX) include a net purchase of 14,000 shares made by Daniel Vitt , and a net purchase of 5,000 shares made by Glenn Whaley .

In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc (IMUX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunic Inc (IMUX) were sold and 19,000 shares were bought by its insiders, resulting in a net purchase of 19,000 shares.

Immunic Inc (IMUX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immunic Inc Insider Transactions

No Available Data

What does Capstone Holding Corp do?

Who are the key executives at Capstone Holding Corp?

Randolph C Steer is the President of Capstone Holding Corp. Other key executives at Capstone Holding Corp include other: See Remarks Alimco Financial Corp , 10 percent owner Neil S Subin , and 10 percent owner Miller Lloyd I Iii .

Capstone Holding Corp (CAPS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Capstone Holding Corp (CAPS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Capstone Holding Corp (CAPS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Capstone Holding Corp (CAPS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Capstone Holding Corp Insider Transactions

No Available Data

What does BioCryst Pharmaceuticals Inc do?

Who are the key executives at BioCryst Pharmaceuticals Inc?

Randolph C Steer is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .

BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary

Over the past 18 months, Randolph C Steer made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .

In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioCryst Pharmaceuticals Inc Insider Transactions

No Available Data

Randolph C Steer Mailing Address

Above is the net worth, insider trading, and ownership report for Randolph C Steer. You might contact Randolph C Steer via mailing address: 614 Mckinley Place Ne, Minneapolis Mn 55413.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.